Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: Optimization of selected culture conditions

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 11, 2012, Pages 1621-1630

  Reichl, Stephan ^a   Becker, Karin ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

cell culture; in vitro permeation; nasal mucosa; RPMI 2650 model

Indexed keywords

POLYETHYLENE; TEREPHTHALIC ACID;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CRYOPRESERVATION; CULTURE MEDIUM; DRUG ABSORPTION; EPITHELIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRANASAL DRUG ADMINISTRATION; MUCOSAL ADMINISTRATION; NOSE MUCOSA; PERMEABILITY; RPMI 2650 CELL LINE; THAWING;

ADMINISTRATION, INTRANASAL; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CRYOPRESERVATION; DEXTRANS; ELECTRIC IMPEDANCE; FLUORESCEIN; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; MODELS, BIOLOGICAL; NASAL MUCOSA; PERMEABILITY; POLYETHYLENE TEREPHTHALATES; PROPRANOLOL; TIME FACTORS;

EID: 84867580307     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01540.x     Document Type: Article

References (37)

1. Ozsoy Y, et al,. Nasal delivery of high molecular weight drugs. Molecules 2009; 14: 3754-3779.
2. Christrup LL, et al,. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther 2008; 30: 469-481.
3. Kaoh HD, et al,. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs. Pharm Res 2000; 17: 978-984.
4. Haschke M, et al,. Pharmacokinetics and pharmacodynamics of nasally delivered midazolam. Br J Clin Pharmacol 2010; 69: 607-616.
5. Duan X, Mao S,. New strategies to improve the intranasal absorption of insulin. Drug Discov Today 2010; 15: 416-427.
6. Barik S,. Intranasal delivery of antiviral siRNA. Methods Mol Biol 2011; 721: 333-338.
7. Jabbal-Gill I,. Nasal vaccine innovation. J Drug Target 2010; 18: 771-786.
8. Jiang Y, et al,. Intranasal delivery of stem cells to the brain. Expert Opin Drug Deliv 2011; 8: 623-632.
9. Agu RU, Ugwoke MI,. In situ and ex vivo nasal models for preclinical drug development studies. In:, Ehrhardt C, Kim KJ, eds. Drug Absorption Studies. New York: Springer, 2008: 112-134.
10. Dimova S, et al,. The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro 2005; 19: 107-122.
11. Kim DD,. In vitro cellular models for nasal drug absorption studies. In:, Ehrhardt C, Kim KJ, eds. Drug Absorption Studies. New York: Springer, 2008: 216-234.
12. Werner U, Kissel T,. Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions. Pharm Res 1995; 12: 565-571.
13. Lee MK, et al,. Air-liquid interface culture of serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Drug Deliv 2005; 12: 305-311.
14. Mallants R, et al,. An improved primary human nasal cell culture for the simultaneous determination of transepithelial transport and ciliary beat frequency. J Pharm Pharmacol 2009; 61: 883-890.
15. Bai S, et al,. Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies. J Pharm Sci 2008; 97: 1165-1178.
16. Wengst A, Reichl S,. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. Eur J Pharm Biopharm 2010; 74: 290-297.
17. Moore GE, Sandberg AA,. Studies of a human tumor cell line with a diploid karyotype. Cancer 1964; 17: 170-175.
18. Werner U, Kissel T,. In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies. Pharm Res 1996; 13: 978-988.
19. Agu RU, et al,. In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies. J Pharm Pharmacol 2001; 53: 1447-1456.
20. Yoo JW, et al,. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Pharm Res 2003; 20: 1690-1696.
21. Peter HG,. Cell culture sheets to study nasal peptide metabolism: the human nasal RPMI 2650 cell line model. Zurich, Switzerland: ETH Zurich, 1996 (dissertation).
22. Kubo H, et al,. In vitro permeation of several model drugs across rabbit nasal mucosa. Int J Pharm 1994; 103: 27-36.
23. Nakamura K, et al,. The enhancing effect of nasal absorption of FITC-dextran 4400 by β-sitosterol β-D-glucoside in rabbits. J Control Release 2002; 79: 147-155.
24. Ohtake K, et al,. Poly-L-arginine predominantly increases the paracellular permeability of hydrophilic macromolecules across rabbit nasal epithelium in vitro. Pharm Res 2003; 20: 153-160.
25. Wadell C, et al,. Permeability of porcine nasal mucosa correlated with human nasal absorption. Eur J Pharm Sci 2003; 18: 47-53.
26. Byrd SR, et al,. Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells. Clin Immunol Immunopathol 1993; 69: 266-271.
27. De Fraissinette A, et al,. Evaluation of the human cell line RPMI 2650 as an in vitro nasal model. Rhinology 1995; 33: 194-198.
28. Salib RJ, et al,. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release. Clin Exp Allergy 2005; 35: 811-819.
29. Patel D, et al,. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain. J Pharm Sci 2012; 101: 690-706.
30. Hahne M, Reichl S,. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. Int J Pharm 2011; 416: 268-279.
31. Nalgene Cryopreservation Application Guide. Available at: http://www.nalgenelabware.com/techdata/application/cryo.pdf (16 May 2012).
32. Rojanasakul Y, et al,. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res 1992; 9: 1029-1034.
33. Reichl S, et al,. In vitro cell culture models to study the corneal drug absorption. Expert Opin Drug Metab Toxicol 2011; 7: 559-578.
34. Schmidt MC, et al,. In vitro cell models to study nasal mucosal permeability and metabolism. Adv Drug Deliv Rev 1998; 29: 51-79.
35. Boucher RC, et al,. Cell culture approaches to the investigation of human airway ion transport. Eur J Respir Dis 1987; 153: 59-67.
36. Cotton CU, et al,. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. J Clin Invest 1987; 79: 80-85.
37. Harikarnpakdee S, et al,. Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer. AAPS PharmSciTech 2006; 7: Article 12.